Russia to mass produce experimental COVID-19 vaccineA larger Phase III trial involving several thousand people is expected to begin in August, Russian Direct Investment Fund (RDIF) head Kirill Dmitriev.Scientists develop a vaccine against the coronavirus disease in Saint Petersburg(photo credit: REUTERS)
